相关实验视频

Updated: Jul 15, 2025

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

葡萄糖脂生物合成辅调剂在胆瘤恶性进展中的作用

Xin Zhang¹, Bo Zeng¹, Haoshuai Zhu¹

¹Department of Thoracic Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.

International journal of biological sciences

|October 2, 2023

概括

分析了常见的中癌 - - 胸腺瘤的代谢重编程. 葡萄糖脂生物合成途径,特别是B3GNT5,显著影响胸腺瘤的进展和患者的存活率,提供潜在的治疗点.

科学领域:

在瘤学瘤学.
代谢学代谢学代谢学
生物信息学是一种生物信息学.

背景情况:

胸腺瘤是最常见的中间骨恶性瘤,涉及显著的代谢重编程.
精确的代谢途径驱动胸腺瘤的发展仍然在很大程度上未被发现.
了解胸腺瘤的代谢环境对于开发有效疗法至关重要.

研究的目的:

阐明与胸腺瘤发育和进展相关的代谢地图.
为了确定关键的代谢途径和基因,有助于胸膜恶性瘤.
评估甲状腺瘤中代谢变化的预后价值.

主要方法:

在TCGA数据集中对代谢途径标记物的无监督聚类,以分类胸腺瘤亚型.
基因本体学 (GO),基因组丰富分析 (GSEA),基因组变异分析 (GSVA) 和基因和基因组的京都百科全书 (KEGG) 路径分析.
转录学与液体染色学-质谱学/质谱学 (LC-MS/MS) 代谢学数据的整合.
使用机器学习分类器来评估预后意义.

主要成果:

胸腺瘤根据代谢途径丰富被分为三个分子上不同的亚型.
鉴定出糖脂生物合成-乳酸和新乳酸系列途径与胸腺瘤预后有显著的相关性.
在该途径内B3GNT5的高表达与患者的生存率差有很强的相关性.
胸腺瘤中的代谢功能障碍受到葡萄糖脂代谢的显著影响.

结论:

葡萄糖脂代谢途径在胸腺瘤进展和患者的结果中发挥着关键作用.
B3GNT5成为了潜在的胆瘤预后生物标志物.
准葡萄糖脂代谢为新型胸腺瘤疗法提供了一个有前途的途径.

关键词:

甘氨基脂是葡萄糖基脂中的一种.质谱学分析的分析.代谢重编程是一种代谢重编程.胸腺瘤是什么意思胸腺瘤是什么意思

更多相关视频

Analysis of SCAP N-glycosylation and Trafficking in Human Cells

Analysis of SCAP N-glycosylation and Trafficking in Human Cells

Published on: November 8, 2016

Glycan Node Analysis: A Bottom-up Approach to Glycomics

Glycan Node Analysis: A Bottom-up Approach to Glycomics

Published on: May 22, 2016

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...